Johnson & Johnson JNJ has just made a significant technical move, achieving a Golden Cross.
This technical pattern occurs when a stock’s short-term moving average crosses above its long-term moving average, indicating a potential shift from a bearish to a bullish trend.
![](https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/29140836/Screenshot-2024-08-29-at-6.36.57-PM-1.png)
Chart created using Benzinga Pro
For Johnson & Johnson, the stock’s 50-day simple moving average (SMA) of $155.36 has crossed above the 200-day SMA of $154.46, signaling strong upward momentum.
Golden Cross: What It Means For Johnson & Johnson Investors
A Golden Cross is considered a bullish indicator, suggesting that Johnson & Johnson stock could be entering a period of sustained upward momentum.
The stock currently trades at $164.43, comfortably above its eight-day SMA of $162.84, 20-day SMA of $161.09 and 50-day SMA of $155.36. These signals collectively point towards strong buying pressure and a bullish trend.
Short-Term Strength: Moving Averages Confirm the Trend
- 8-Day SMA: With Johnson & Johnson stock trading at $164.43 against the eight-day SMA of $162.84, the short-term outlook remains bullish.
- 20-Day SMA: The 20-day SMA stands at $161.09, also below the current price, reinforcing the bullish sentiment.
- 50-Day SMA: Johnson & Johnson stock’s 50-day SMA of $155.36 further supports the bullish narrative, as the stock remains well above this level.
- 200-Day SMA: The long-term trend remains bullish as the current price far exceeds the 200-day SMA of $154.46.
Fundamental Backing: Positive Catalysts Ahead
Johnson & Johnson’s recent submission of a Biologics License Application (BLA) to the FDA for nipocalimab, aimed at treating generalized myasthenia gravis (gMG), adds a strong fundamental tailwind to the stock.
The company's ongoing efforts to expand its oncology pipeline, combined with strategic acquisitions like V-Wave Ltd., are set to bolster its growth prospects.
Bullish Signals For Johnson & Johnson
With the Golden Cross in play and a series of fundamental catalysts on the horizon, Johnson & Johnson’s stock appears poised for continued strength.
The bullish technical indicators and the company’s strategic initiatives position Johnson & Johnson as a compelling opportunity for investors looking to capitalize on its upward momentum.
Read Next:
Image: Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.